These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8049422)

  • 1. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
    Koeleman BP; Reitsma PH; Allaart CF; Bertina RM
    Blood; 1994 Aug; 84(4):1031-5. PubMed ID: 8049422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
    Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
    Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
    Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
    Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.
    Beauchamp NJ; Daly ME; Hampton KK; Cooper PC; Preston FE; Peake IR
    Br J Haematol; 1994 Sep; 88(1):219-22. PubMed ID: 7803250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
    Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
    Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients.
    Lensen RP; Rosendaal FR; Koster T; Allaart CF; de Ronde H; Vandenbroucke JP; Reitsma PH; Bertina RM
    Blood; 1996 Dec; 88(11):4205-8. PubMed ID: 8943855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
    Ma DD; Aboud MR; Williams BG; Isbister JP
    Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of activated protein C resistance(APC-R) and FV Leiden in healthy blood donors and patients with thrombosis].
    Hong M; Wei W; Song S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):455-7. PubMed ID: 11189481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation.
    McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene mutations in 21 unrelated cases of phenotypic heterozygous protein C deficiency and thrombosis. Protein C Study Group.
    Ireland H; Thompson E; Lane DA
    Thromb Haemost; 1996 Dec; 76(6):867-73. PubMed ID: 8972002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.